What it is

Mexa Design is our AI-powered platform that creates cyclic peptide drug candidates from scratch — even when no experimental leads exist. It turns the toughest starting point in drug discovery into a concrete set of optimized candidates.

Why it’s different

• In silico first – Structure-based rational drug design, not random screening.
• AI-enhanced chemical space – Beyond traditional docking, our AI expands the cyclic peptide universe to include non-canonical amino acids.
• Synthesizable candidates – Algorithms are tuned to ensure amino acids are available for real-world synthesis.
• Customizable – Add up to five of your own non-canonical amino acids to the design pool.

Who it’s for

• Researchers with new biological targets but no starting chemistry.
• Teams interested in exploring cyclic peptide modalities.
• Projects focusing on competitive inhibition, receptor inhibition, radiopharmaceutical targets, or protein–protein interfaces.

 

What you get

• 15 cyclic peptide drug candidates, optimized for binding affinity and drug-like properties.

 

 

FAQ Highlights

• Is this in silico design? – Yes. Structure-based design combined with AI-generated chemical space.
• Why trust the results? – High-accuracy computational methods, validated workflows, and synthetic feasibility checks.
• Are candidates closer to drugs? – They are optimized starting points. Binding is central, and optimized for drug-like properties. To obtain drug candidates, project-based development is required.
• Can you add my amino acid? – Yes. We can integrate your custom amino acids into the design pool.